|
|
Journal of Cancer 2019
Incidence of Ipilimumab-Related Serious Adverse Events in Patients with Advanced Cancer: A Meta-AnalysisDOI: 10.7150/jca.28120 Keywords: incidence, ipilimumab, serious adverse events, meta-analysis, risk factors Abstract: Background: Little is known about the incidence of ipilimumab-related serious adverse events (SAEs) across various tumor types, drug doses and treatment regimens.
|
